Srx Health Solutions, Inc. · AMEX:SRXH
Srx Health Solutions — Investor Presentation (June 2025)
19 slides from Srx Health Solutions's investor presentation, Jun 13, 2025
Slide 1: SRx Corporate Presentation
SRx Corporate Presentation June 2025 SR. HEALTH SOLUTIONS Making Healthcare Simple
Slide 2: Forward Looking Statements
Forward Looking Statements The information in this presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contain
Slide 3: Leadership Team
Leadership Team Michael Young Board of Directors Michael Young is@ member ofthe Board of Directors at SR Heath Soliions. Pio to SR, Michael served ‘8 Chairman of Better Chale Company, Which subsequent merged with SR ‘tonally, Mchoe isthe founding partner of Cotingham Capa. Michael has extensive srio
Slide 4: A Lifelong Mission to Provide Quality Patient Care
A Lifelong Mission to Provide Quality Patient Care “After years in retail pharmacy, | felt that the system was broken and needed to create a more patient-centric approach to support patients with chronic diseases.” SRx’s Start Founded in 2018 by Adesh Vora, after suocesstlly exiting chain of retail
Slide 5: SRx At a Glance
SRx At a Glance What Are Specialty Pharmacies? @ Specialty pharmacies service patients with chronic diseases @ Deliver care and support that retail pharmacies cannot provide 34 Specialty Health Clinics 20 Specialty Pharmacies ~$145M Revenue For the nine months endes 6/30/2025" 4 400+ Clinical Trial
Slide 6: Creating a North American Network
Creating a North American Network The SRx Network extends across Canada, making it one of the most accessible providers of specially healthcare in the country With 5 sites in Texas and licenses to distribute across 26 US states, the acquisition of Choice Specialty Pharmacy enhances SRx's US presence
Slide 7: SRx Ecosystem of Specialty Healthcare Services
SRx Ecosystem of Specialty Healthcare Services SRx's specialty pharmacies serve as the foundation to the Company's integrated network All-Inclusive Specialty Pharmacies 20 pharmacies across Canada, providing personalized services, Capable of dispensing specialty, regular, and compounded medications,
Slide 8: Complex Patient Care Ecosystem
Complex Patient Care Ecosystem The SRx network represents a critical link in facilitating specialty care Partner Physician Referral Patient referred to SRx for specialty Patient Onboarding therapeutic treatment Introductory call, counseling, pre- & screening and other administrative requirements Pre
Slide 9: Strong Industry Tailwinds
Strong Industry Tailwinds Growing Prevalence of The Need for Specialty Market Attractiveness Chronic Disease in Seniors Pharmacists in Canada US specialty drug spend, Of Canadians aged 65+ 5 million Canadians are without . 73% JB report having at least 1 SG access to aprimary heatincare _-—~$410B_ r
Slide 10: Focus on Partnerships
Focus on Partnerships © © @ 6 6 6 Continued YoY Physician Patient Support Phameseaen th Partnerships Programs Continued Continued Developing Y same store % relationships & comprehensive pharmacy YoY with providers to care programs growth of 8% deliver the best with new and care possible innovative t
Slide 11: Strategic Growth
Strategic Growth About Choice Specialty Pharmacy Choice Specialty Pharmacy is a fully licensed provider of specialized pharmacy services in the U.S., dedicated to delivering efficient, compassionate, and innovative pharmaceutical care Binding LOI to acquire 100% of Choice Specialty Pharmacy Group si
Slide 12: Summary Income Statement: Unaudited Pro Forma Combined
Summary Income Statement: Unaudited Pro Forma Combined (in thousands of USD) ing Adjustments Total Combined Net sales 27,817 117,109 144,926 Cost of sales 17,432 93,685 414,117 Gross profit 10,385 23,424 33,809 Operating expenses 14,703 31,624 (376) 45,951 Other income (expense) 5,670 (3,328) 2,342
Slide 13: Summary Balance Sheet: Unaudited Pro Forma Combined
Summary Balance Sheet: Unaudited Pro Forma Combined (in thousands of USD) eteri Choice Accounting Adjustments Total Combined Cash and cash equivalents 4,743 489 5,232 Total assets 17,172 64,002 (1,855) 79,319 Total current liabilities 6,852 74,642 81,494 Total liabilities 6,873 82,065 88,938 Total s
Slide 14: Pro Forma Capitalization Table
Pro Forma Capitalization Table Pro Forma Including Shares issued to SRx Health Solutions Shares Outstanding’ 35,233,010 Ownership Options (WAEP: $105.44) 99,400 Non Aes Warrants (WAEP: $148.64) 269,345 aa Fully Diluted Shares Outstanding! SOT Combined Net Debt (uso)? $39.4 MM ssinsidors Non-Attiiate
Slide 15: Investment Highlights
Investment Highlights Strong Industry Robust Strategic Rapidly Expanding Tailwinds Partnerships Healthcare Network 34 Specialty Health Clinics Of Canadians aged 65+ report having at least 1 Prescribers 4 Clinical Trial Sites chronic disease 20 Specialty Pharmacies 5 million Canadians are without Pro
Slide 16: Slide 16
Slide 17: APPENDIX
APPENDIX
Slide 18: Halo Overview
iii HALO OVERVIEW Rich in benefits of a Designed forthe pet parent seeking Halo complete cigestive heath wih prebiotes, probiotics and postbiotics. Additionally, page. its one of the only brands made with only holistic oie animal proteins ané no meat meals ELEVATE Rooted in Nature Targeting most att
Slide 19: Pro Forma Combined Debt Overview
Pro Forma Combined Debt Overview (As of September 30, 2024) Debt (USD millions) % Total Coupon PIK or Cash Interest Maturity Term Loan $33.9 86% 88% Cash Interest 2027 - In Forbearance Bank Indebtedness $3.6 9% Prime + 2.25% Cash Interest 2027 Wintrust Receivables Credit Facility $19 5% Prime + 2.5%
SRx Health Solutions — Investor Presentation (June 2025) on 6ix